Evotec CEO: Growth Prospects Rely Heavily On Roche, Sanofi Deals
This article was originally published in The Pink Sheet Daily
Executive Summary
After disappearance last year of its drug hope DiaPep277 due to fraud, Germany’s Evotec is now looking to its Alzheimer’s MAO partnership with Roche and newly entered R&D alliance with Sanofi for future growth.